TransMedics Group, Inc. TMDX Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $7.32M-71.5% | $105.38M+1,437% | $24.32M+477% | $34.91M+186% | $25.68M+111% | ||
| $11.86M+93.3% | $7.47M+31.5% | $6.85M+32.3% | $6.73M+46.4% | $6.14M+42.7% | ||
| $9.95M+11.1% | $9.4M-12.7% | $9.14M+15.0% | $9.37M+22.6% | $8.96M+30.4% | ||
| $1.07M+105% | -$20.89M— | -$20.89M— | -$20.89M— | -$20.89M— | ||
| —— | —— | —— | —— | -$80K-1,782% | ||
| $6.52M-85.2% | —— | -$24.15M-374% | —— | $44.13M+140% | ||
| $3.9M+295% | $6.53M— | $6.9M+51.4% | -$3.71M-260% | -$2M-136% | ||
| $1.13M+44.2% | -$2.06M+34.2% | $2.46M+6,919% | -$1.19M-131% | $781K+138% | ||
| -$3.11M+33.1% | $6.97M+200% | $13.14M+164% | $2.23M+229% | -$4.64M-9,378% | ||
| $155K— | $13K-73.5% | $6K-92.1% | —— | —— | ||
| $40K-87.9% | —— | $1.74M+137% | -$522K+14.7% | $330K+206% | ||
| -$805K-21.2% | -$777K-21.6% | -$740K-18.2% | -$714K-41.7% | -$664K-33.9% | ||
| $24.53M+959% | $34.51M+75.5% | $69.57M+915% | $91.61M+256% | -$2.86M+16.9% | ||
| $36.66M+35.6% | $15.51M+14.0% | $7.62M-84.2% | $9.08M-61.8% | $27.04M-38.8% | ||
| -$36.66M-35.6% | -$15.51M-14.0% | -$7.62M+84.0% | -$9.08M+61.8% | -$27.04M+38.8% | ||
| —— | —— | —— | —— | —— | ||
| $2.21M+27.0% | $3.1M+161% | $1.82M-71.8% | $7.09M-33.4% | $1.74M-31.6% | ||
| $138K+300% | $34.5K— | $34.5K— | $34.5K— | $34.5K— | ||
| $3.76M+24.2% | $3.1M+161% | $3.64M-53.7% | $7.09M-33.4% | $3.03M-4.9% | ||
| -$327K-191% | $94K+114% | $9K-97.7% | $809K+1,405% | $358K+307% | ||
| -$8.69M+67.2% | $22.19M— | $65.6M+301% | $90.43M— | -$26.51M+40.6% | ||
| —— | $2.68M-5.3% | $2.68M-5.3% | $2.68M-5.3% | $2.68M-5.3% | ||
| -$486K-185% | $141K+115% | $8K-98.3% | $900K+90,100% | $573K+388% | ||
| —— | —— | —— | —— | -$80K-1,782% | ||
| -$3.11M+33.1% | $6.97M+200% | $13.14M+164% | $2.23M+229% | -$4.64M-9,378% | ||
| -$805K-21.2% | -$777K-21.6% | -$740K-18.2% | -$714K-41.7% | -$664K-33.9% | ||
| -$1.96M-1.7% | —— | $5.9M+107% | —— | -$1.93M-222% | ||
| $4.59M+484% | —— | —— | —— | $787K— | ||
| $610K+28.7% | —— | —— | —— | $474K— | ||
| $1.69M+31.3% | —— | $1.96M+37.9% | —— | $1.29M+102% | ||
| $1.1M-3.0% | $0-100% | $548K— | $104K-71.1% | $1.14M-3.7% | ||
| —— | —— | —— | —— | —— | ||
| -$805K-21.2% | -$777K-21.6% | -$740K-18.2% | -$714K-41.7% | -$664K-33.9% | ||
| $2.83M+122% | $2.16M+77.9% | $1.27M+4.9% | $976K-54.9% | $1.28M+4.9% | ||
| $3.99M— | —— | —— | —— | —— | ||
| $340.04M— | —— | —— | —— | —— | ||
| $313K— | —— | $471K+25.7% | —— | —— | ||
| -$12.12M+59.4% | $19M— | $61.95M+250% | $82.53M— | -$29.89M+37.2% | ||
| -$12.12M+59.4% | $19M— | $61.95M+250% | $82.53M— | -$29.89M+37.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does TransMedics Group, Inc. generate?
- TransMedics Group, Inc. (TMDX) generated $220.2M in operating cash flow over the trailing twelve months.
- What is TransMedics Group, Inc.'s free cash flow?
- After $68.9M of capital expenditures, TransMedics Group, Inc.'s free cash flow was $151.4M over the trailing twelve months, up 199.3% year over year.
- Where does TransMedics Group, Inc.'s cash flow data come from?
- Every line is extracted from TransMedics Group, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
